维普中文期刊产品整合服务

Bile acid receptors link nutrient sensing to metabolic regulation

查看全文 作  者:Jibiao [1]Li;Tiangang [1]Li 高影响力作者 机构地区:[1]Department of Pharmacology,Toxicology and Therapeutics,University of Kansas Medical Center,3901 Rainbow Blvd,Kansas City,KS,USA高影响力机构 出  处:《Liver Research》索引2017年第1卷第1期,共9页高影响力期刊 基  金:This work was supported in part by an American Diabetes Association Junior Faculty Award 7-12-JF-35;National Institutes of Health grants 1R01DK102487-01 and P20GM103549&P30GM118247. 摘  要:Non-alcoholic fatty liver disease(NAFLD)is a common liver disease in Western populations.Nonalcoholic steatohepatitis(NASH)is a more debilitating form of NAFLD characterized by hepatocellular injury and inflammation,which significantly increase the risk of end-stage liver and cardiovascular diseases.Unfortunately,there are no available drug therapies for NASH.Bile acids are physiological detergent molecules that are synthesized from cholesterol exclusively in the hepatocytes.Bile acids circulate between the liver and intestine,where they are required for cholesterol solubilization in the bile and dietary fat emulsification in the gut.Bile acids also act as signaling molecules that regulate metabolic homeostasis and inflammatory processes.Many of these effects are mediated by the bile acid-activated nuclear receptor farnesoid X receptor(FXR)and the G protein-coupled receptor TGR5.Nutrient signaling regulates hepatic bile acid synthesis and circulating plasma bile acid concentrations,which in turn control metabolic homeostasis.The FXR agonist obeticholic acid has had beneficial effects on NASH in recent clinical trials.Preclinical studies have suggested that the TGR5 agonist and the FXR/TGR5 dual agonist are also potential therapies for metabolic liver diseases.Extensive studies in the past few decades have significantly improved our understanding of the metabolic regulatory function of bile acids,which has provided the molecular basis for developing promising bile acid-based therapeutic agents for NASH treatment. 关 键 词:Nuclear receptor TGR5 Metabolic syndromes Fatty liver disease
相关文献

参考文献(131)

引证文献(2)

耦合文献(70)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费